(Q40891323)

24 September 2017

1 reference

title

Concepts of antibody-mediated cancer therapy (English)

1 reference

24 September 2017

Kummer U

1

1 reference

24 September 2017

Staerz UD

series ordinal

2

1 reference

24 September 2017

publication date

1 January 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

11

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

174-184

1 reference

Structural basis of antibody function

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

The role of membrane receptors for C3b and C3d in phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-Thy-1.2 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Evidence for three types of human cytotoxic lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Lymphocyte-dependent antibodies to antigen 3.1, a cell-surface antigen expressed by a subgroup of human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Higher cytolytic efficiency of an IgG2α than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Selective chemical catalysis by an antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

A hapten-specific chimaeric IgE antibody with human physiological effector function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

The immunogenicity of chimeric antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Reshaping human antibodies: grafting an antilysozyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Inhibition of Human Acute Lymphoblastic Leukemia Cells by Immunotoxins: Potentiation by Chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Fusion of Two Immunoglobulin-producing Myeloma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

The isolation of heterokaryons and hybrids by a selective system using irreversible biochemical inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Hybrid antibodies can target sites for attack by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Use of anti-receptor antibodies to focus T-cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Hybrid antibody-mediated lysis of virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

In vivo localization of a bispecific antibody which targets human T lymphocytes to lyse human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Induction of cytotoxicity in human T cells coated with anti-glioma x anti-CD3 bispecific antibody against human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

The binding site for C1q on IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Recombinant antibodies possessing novel effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Hybrid hybridomas and their use in immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

Thymic selection process induced by hybrid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024836

10.3109/07357909309024836

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference